Dr. Kathy Rodgers, Associate Director of Translational Neuroscience, and her research team are investigating a drug that may benefit people with Lou Gehrig’s disease.
https://arizonaalumni.com/arizona-magazine/fall-2022/hope-als-patients
Find out more about current clinical trials and studies. Learn more
Dr. Kathy Rodgers, Associate Director of Translational Neuroscience, and her research team are investigating a drug that may benefit people with Lou Gehrig’s disease.
https://arizonaalumni.com/arizona-magazine/fall-2022/hope-als-patients